Clik here to view.
Teva’s Fremanezumab Meets all Primary & Secondary Endpoints Across Both...
Wednesday, June 7th 2017 at 12:00pm UTC Statistically and clinically significant results demonstrate fremanezumab’s efficacy and safety, including unique quarterly subcutaneous dosing regimen, and in...
View ArticleClik here to view.
Kite to Present at June 2017 Investor Conferences
Tuesday, June 6th 2017 at 12:30pm UTC SANTA MONICA, Calif.–(BUSINESS WIRE)– Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that management will present at two...
View ArticleClik here to view.
Update: Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare...
Thursday, June 8th 2017 at 1:17pm UTC PRINCETON, N.J.–(BUSINESS WIRE)– Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company developing cancer immunotherapies, announced that Daniel J....
View ArticleClik here to view.
Burtomab Receives Breakthrough Therapy Designation for Advanced Form of...
Wednesday, June 7th 2017 at 8:50pm UTC NEW YORK–(BUSINESS WIRE)– Burtomab, a drug for metastatic neuroblastoma, created by Memorial Sloan Kettering Cancer Center (MSK) and licensed to Y-mAbs...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part in Goldman Sachs 38th Annual Global...
Wednesday, June 7th 2017 at 10:59am UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will take part in Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, June...
View ArticleClik here to view.
Acorda Presenting New Tozadenant Data at 2017 MDS Congress
Tuesday, June 6th 2017 at 10:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq: ACOR) is presenting new data from clinical and preclinical studies of tozadenant at the 2017...
View ArticleClik here to view.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at...
Wednesday, June 7th 2017 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President,...
View ArticleClik here to view.
Teva to Present at the Jefferies 2017 Global Healthcare Conference
Tuesday, June 6th 2017 at 12:00pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Jefferies 2017 Global Healthcare...
View ArticleClik here to view.
Enzo Biochem Announces New York State Health Department Approval of New...
Thursday, June 8th 2017 at 8:00pm UTC Underscores Enzo’s Growing Test Menu of High Performing Molecular Diagnostics NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New...
View ArticleClik here to view.
Bristol-Myers Squibb Announces Dividend
Tuesday, June 13th 2017 at 8:05pm UTC NEW YORK–(BUSINESS WIRE)– The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-nine cents ($0.39) per...
View ArticleClik here to view.
Cellectis: Annual General Meeting of June 26, 2017
Friday, June 9th 2017 at 8:48pm UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company...
View ArticleClik here to view.
Teva Announces Launch of Generic Zetia® in the United States
Monday, June 12th 2017 at 7:16pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Zetia®1 (ezetimibe) tablets, 10 mg, in...
View ArticleClik here to view.
Navidea’s Commercial Partner, Norgine B.V., Launches LYMPHOSEEK® in Europe
Monday, June 12th 2017 at 3:06pm UTC LYMPHOSEEK® Represents Next-Generation Standard of Diagnosis For Sentinel Lymph Node Detection LYMPHOSEEK® Commercialized in Three Major European Countries DUBLIN,...
View ArticleClik here to view.
Bristol-Myers Squibb to Announce Results for Second Quarter 2017 on July 27
Monday, June 12th 2017 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2017 on Thursday, July 27, 2017. During a...
View ArticleClik here to view.
Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Tuesday, June 13th 2017 at 12:00pm UTC Global Phase 3 program is studying potential new treatment option for millions of people living with chronic pain associated with osteoarthritis and chronic low...
View ArticleClik here to view.
Audax Private Equity Announces the Acquisition of Altasciences Clinical Research
Tuesday, June 13th 2017 at 2:33pm UTC BOSTON–(BUSINESS WIRE)– Audax Private Equity (“Audax”) announced that it has partnered with management to acquire Altasciences Company, Inc. (“Altasciences”), a...
View ArticleClik here to view.
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for...
Friday, June 9th 2017 at 12:00pm UTC – Amendment accelerates anticipated PROSPER top-line results by two years – – Target sample size reduced to approximately 1,440 patients and estimated primary...
View ArticleClik here to view.
PsychoGenics Achieves a Milestone in Drug Discovery Collaboration with Sunovion
Monday, June 12th 2017 at 5:44pm UTC TARRYTOWN, N.Y.–(BUSINESS WIRE)– PGI Drug Discovery LLC (PsychoGenics), announced that Sunovion Pharmaceuticals Inc. filed an IND for SEP-378608 triggering a...
View ArticleClik here to view.
Only 17% of People Rank Health-Related Sectors as Most Innovative, but 40%...
Monday, June 12th 2017 at 2:03pm UTC Klick Health consumer study highlights four key insights: Desire for increased innovation in healthcare Belief that healthcare innovation will enhance...
View ArticleClik here to view.
teckro. Appoints Ashley Parish as Vice President, Strategic Alliances
Thursday, June 15th 2017 at 4:40pm UTC NEW YORK–(BUSINESS WIRE)– teckro, a global life sciences mobile technology company that helps pharmaceutical and biotech organizations improve their clinical...
View Article